申请人:Boyce Christopher W.
公开号:US20130303517A1
公开(公告)日:2013-11-14
The invention provides certain quinoxalines and aza-quinoxalines of the Formula (I), and their pharmaceutically acceptable salts, wherein J
1
, J
2
, R
1
, R
2
, R
3
, R
22
, R
a
, R
b
, R
c
, R
d
, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTH
2
function.
本发明提供了式(I)的某些喹喔啉和氮杂喹喔啉,以及其药学上可接受的盐,其中J1、J2、R1、R2、R3、R22、Ra、Rb、Rc、Rd、X、Y、b、n和q如本文所定义。本发明还提供了包含这些化合物的制药组合物,并使用这些化合物治疗与CRTH2功能不受控制或不适当刺激相关的疾病或病症的方法。